MWOGX
Price
$50.74
Change
-$1.28 (-2.46%)
Updated
Dec 18 closing price
RNPEX
Price
$64.62
Change
-$2.05 (-3.07%)
Updated
Dec 18 closing price
Ad is loading...

MWOGX vs RNPEX

Header iconMWOGX vs RNPEX Comparison
Open Charts MWOGX vs RNPEXBanner chart's image
MFS Global Growth R1
Price$50.74
Change-$1.28 (-2.46%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R4
Price$64.62
Change-$2.05 (-3.07%)
VolumeN/A
CapitalizationN/A
MWOGX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MWOGX vs. RNPEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MWOGX is a Buy and RNPEX is a Buy.

FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 149B vs. MWOGX (993M). RNPEX pays higher dividends than MWOGX: RNPEX (0.83) vs MWOGX (0.00). MWOGX was incepted earlier than RNPEX: MWOGX (20 years) vs RNPEX (23 years). MWOGX is a more actively managed with annual turnover of: 24.00 vs. RNPEX (17.00). MWOGX has a lower initial minimum investment than RNPEX: MWOGX (0) vs RNPEX (250). RNPEX annual gain was more profitable for investors over the last year : 23.10 vs. MWOGX (10.40). RNPEX return over 5 years is better than : 40.88 vs. MWOGX (27.19).
MWOGXRNPEXMWOGX / RNPEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD12.50021.48358%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets993M149B1%
Annual Yield % from dividends0.000.83-
Returns for 1 year10.4023.1045%
Returns for 3 years3.777.2252%
Returns for 5 years27.1940.8867%
Returns for 10 years72.7776.0596%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHD105.80-0.02
-0.02%
Church & Dwight Co
BZH30.01-0.61
-1.99%
Beazer Homes USA
ESEA34.12-0.76
-2.18%
Euroseas Ltd
BHVN39.12-2.32
-5.60%
Biohaven Ltd
NXTC0.90-0.11
-10.82%
NextCure